The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EATON: An open-label, multicenter, phase I dose-escalation trial of nazartinib (EGF816) and trametinib in patients with EGFR-mutant non-small cell lung cancer – preliminary data on safety and tolerability.
 
Sebastian Yves Friedrich Michels
Honoraria - AstraZeneca; Boehringer Ingelheim; Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Boehringer Ingelheim; Pfizer; Roche Pharma AG
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis
 
Lucia Nogova
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Janssen (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Celgene; Novartis; Pfizer
 
Barbara Deschler-Baier
No Relationships to Disclose
 
Enriqueta Felip
Consulting or Advisory Role - Abbvie; AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Guardant Health; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Takeda
Research Funding - EMD Serono (Inst); Merck (Inst)
 
Delvys Rodriguez-Abreu
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche
 
Rafael Rosell
No Relationships to Disclose
 
Martin Sebastian
Honoraria - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer/EMD Serono; Roche/Genentech; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Novartis; Pfizer; Roche/Genentech; Takeda
Travel, Accommodations, Expenses - Pfizer; Takeda
 
Martin H. Schuler
Honoraria - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Roche
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Highly sensitive method for mutation detection by PCR (Inst)
 
Martin Wermke
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dome; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Kite, a Gilead company; Novartis
Travel, Accommodations, Expenses - Glenmark
 
Rieke Nila Fischer
Honoraria - Bristol-Myers Squibb; MSD; Roche
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Mediolanum Farmaceutici
 
Sophia Koleczko
No Relationships to Disclose
 
Diana S.Y. Abdulla
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Healthcare Consulting Cologne; MSD; Novartis; Roche Pharma AG
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; Healthcare Consulting Cologne; MSD; Novartis; Roche Pharma AG
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Janssen Research & Development (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Loxo; Merck; Novartis; Roche Pharma AG
 
Richard Riedel
Consulting or Advisory Role - Boehringer Ingelheim; Novartis
Travel, Accommodations, Expenses - Lilly; Loxo
 
Matthias Scheffler
Honoraria - Boehringer Ingelheim; Healthcare Consulting Cologne; Mediolanum Farmaceutici; Roche; Takeda
Consulting or Advisory Role - Boehringer Ingelheim; Mediolanum Farmaceutici; Roche; Takeda
Travel, Accommodations, Expenses - Boehringer Ingelheim; Mediolanum Farmaceutici
 
Jana Fassunke
Honoraria - AstraZeneca
 
Martin Hellmich
No Relationships to Disclose
 
Sabine Merkelbach-Bruse
Honoraria - AstraZeneca; Bristol-Myers Squibb; Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer
 
Reinhard Buettner
Stock and Other Ownership Interests - Co-Founder and CSO for Targos Mol. Pathol., Inc (Kassel/Germany) and TAMP (Atlanta/USA)
Honoraria - Abbvie; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Pfizer; Qiagen; Roche
Research Funding - Roche (Inst)
 
Juergen Wolf
Honoraria - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Ignyta; Janssen; Lilly; Loxo/Lilly; MSD Oncology; Novartis; Pfizer; Roche
Research Funding - Bristol-Myers Squibb; Janssen; Novartis; Pfizer